Bausch Health Companies Inc

TSX:BHCCanadaView on NYSE

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

Contact Information

Headquarters

2150 Saint-Elzear Blvd WLAVAL, QC, Canada H7L 4A8

Phone

514-744-6792

Fax

514-744-6792

Executives

Independent Chairman of the Board

John Paulson

Chief Executive Officer, Director

Thomas Appio

Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Controller

John Barresi

Executive Vice President, General Counsel

Seana-Lyn Carson

Independent Director

Brett Icahn